Workflow
Xenon(XENE) - 2024 Q4 - Earnings Call Transcript
XENEXenon(XENE)2025-02-28 09:31

Xenon Pharmaceuticals (XENE) Q4 2024 Earnings Call February 28, 2025 05:31 AM ET Company Participants Chad Fugere - VP - IRIan Mortimer - President and CEOChristopher Kenney - Chief Medical OfficerSherry Aulin - CFOPaul Matteis - Managing Director, Head of Therapeutics ResearchCaroline Pocher - Associate, Equity Research (SMid Cap Biotechnology)Matthew Barcus - Senior Research AssociateJason Gerberry - MD & Equity ResearchDouglas Tsao - Managing Director Conference Call Participants None - AnalystBrian Skor ...